International, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of RPH-104 Treatment in Patients With Recurrent Pericarditis
Latest Information Update: 16 Feb 2023
At a glance
- Drugs Goflikicept (Primary)
- Indications Pericarditis
- Focus Registrational; Therapeutic Use
- Sponsors R-Pharm
- 09 Feb 2023 Planned initiation date changed from 1 Sep 2022 to 1 Dec 2023.
- 02 Jun 2022 Planned initiation date changed from 1 Mar 2022 to 1 Sep 2022.
- 09 Nov 2021 New trial record